Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with fewer side effects.

Corneal disease in vernal keratoconjunctivitis and atopic keratoconjunctivitis currently requires aggressive treatment with topical steroids. In the future, better identification of the ...

The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for ...

Discover the key differences between allergy-related throat pain and more concerning conditions with expert-backed indicators for effective treatment procedures ...

Also Read: ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024 Most commercially insured patients will pay ...

The allergic reaction can be severe, requiring emergency medical treatment. Fatal reactions are rare. Check whether they are carrying an epinephrine pen. If they are, follow the instructions on ...

If severe reactions in the skin and more generalized symptoms occur, the doctor may refer the person to a specialist for desensitization or treatment for an allergic reaction. If symptoms worsen ...

Without treatment, anaphylaxis can result in death. A primary care physician or an allergist can diagnose allergic reactions.

Cash Position & Operating Runway : As of December 31, 2024, ARS Pharma had cash, cash equivalents, and short-term investments of $314.0 million, with 97,954,172 shares of common stock outstanding. The ...